Efficacy of short-term adjunctive subantimicrobial dose doxycycline in diabetic patients - randomized study

Oral Diseases

Volumn 18, Issue 8, 2012, Pages 763-770

  Gilowski, L ^a,b   Kondzielnik, P ^a,c   Wiench, R ^a   Plocica I ^a   Strojek, K ^a   Krzeminski T F ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b Private Dental Practice   (Poland)

^c Silesian Centre of Heart Diseases Medical University of Silesia ^*  (Poland)

Author keywords

Diabetes mellitus; Host modulation therapy; Matrix metalloproteinase; Periodontitis; Scaling and root planing; Subantimicrobial dose doxycycline

Indexed keywords

DOXYCYCLINE; HEMOGLOBIN A1C; NEUTROPHIL COLLAGENASE; PLACEBO;

ADULT; AGED; ANTIMICROBIAL ACTIVITY; ARTICLE; CHRONIC PERIODONTITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DOUBLE BLIND PROCEDURE; FEMALE; GINGIVITIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVENTIVE DENTISTRY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SHORT COURSE THERAPY; TREATMENT DURATION;

ADULT; AGED; ANTI-BACTERIAL AGENTS; CHRONIC PERIODONTITIS; DENTAL PLAQUE INDEX; DENTAL SCALING; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; DOXYCYCLINE; FEMALE; FOLLOW-UP STUDIES; GINGIVAL CREVICULAR FLUID; GINGIVITIS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MATRIX METALLOPROTEINASE 8; MIDDLE AGED; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL POCKET; PLACEBOS; ROOT PLANING; TREATMENT OUTCOME;

EID: 84866863512     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2012.01943.x     Document Type: Article

References (51)

1. Ainamo J, Bay I (1975). Problems and proposals for recording gingivitis and plaque. Int Dent J25: 229-235.
2. Aldridge JP, Lester V, Watts TLP, Collins A, Viberti G, Wilson RF (1995). Single-blind studies of the effects of improved periodontal health on metabolic control in type 1 diabetes mellitus. J Clin Periodontol22: 271-275.
3. Aspriello SD, Zizzi A, Tirabassi G et al (2011). Diabetes mellitus-associated periodontitis: differences between type 1 and type 2 diabetes mellitus. J Periodontal Res46: 164-169.
4. Caton JG, Ciancio SG, Blieden TM et al (2000). Treatment with subantimicrobial dose doxycycline improves the efficacy of scaling and root planing in patients with adult periodontitis. J Periodontol71: 521-532.
5. Chen HY, Cox SW, Eley BM, Mantyla R, Ronka H, Sorsa T (2000). Matrix metalloproteinase-8 levels and elastase activities in gingival crevicular fluid from chronic adult periodontitis patients. J Clin Periodontol27: 366-369.
6. Chen L, Wei B, Li J et al (2010). Association of periodontal parameters with metabolic level and systemic inflammatory markers in patients with type 2 diabetes. J Periodontol81: 364-371.
7. Choi DH, Moon IS, Choi BK et al (2004). Effects of sub-antimicrobial dose doxycycline therapy on crevicular fluid MMP-8, and gingival tissue MMP-9, TIMP-1 and IL-6 levels in chronic periodontitis. J Periodontal Res39: 20-26.
8. Christgau M, Palitzsch KD, Schmalz G, Kreiner U, Frenzel S (1998). Healing response to non-surgical periodontal therapy in patients with diabetes mellitus: clinical, microbiological, and immunological results. J Clin Periodontol25: 112-124.
9. Correa FOB, Goncalves D, Figueredo CMS, Bastos AS, Gustefsson A, Orrico SRP (2010). Effect of periodontal treatment on metabolic control, systemic inflammation and cytokines in patients with type 2 diabetes. J Clin Periodontol37: 53-58.
10. Crout RJ, Lee HM, Schroeder K et al (1996). The "cyclic" regimen of low-dose doxycycline for adult periodontitis: a preliminary study. J Periodontol67: 506-514.
11. da Cruz GA, de Toledo S, Sallum EA et al (2008). Clinical and laboratory evaluations of non-surgical periodontal treatment in subjects with diabetes mellitus. J Periodontol79: 1150-1157.
12. Deo V, Gupta S, Bhongade ML, Jaiswal R (2010). Evaluation of subantimicrobial dose doxycycline as an adjunct to scaling and root planing in chronic periodontitis patients with diabetes: a randomized, placebo-controlled clinical trial. J Contemp Dent Pract11: 9-16.
13. Emingil G, Atilla G, Sorsa T, Luoto H, Kirilmaz L, Baylas H (2004). The effect of adjunctive low-dose doxycycline therapy on clinical parameters and gingival crevicular fluid matrix metalloproteinase-8 levels in chronic periodontitis. J Periodontol75: 106-115.
14. Engebretson SP, Hey-Hadavi J (2011). Sub-antimicrobial doxycycline for periodontitis reduces hemoglobin A1c in subjects with type 2 diabetes: a pilot study. Pharmacol Res64: 624-629.
15. Golub LM, Ramamurthy N, McNamara TF et al (1984). Tetracyclines inhibit tissue collagenases activity. A new mechanism in the treatment of periodontal disease. J Periodontal Res19: 651-655.
16. Golub LM, Ciancio S, Ramamurthy N, Leung M, McNamara TF (1990). Low-dose doxycykline therapy: effect on gingival and crevicular fluid collagenase activity in humans. J Periodontal Res25: 321-330.
17. Golub LM, Lee HM, Ryan ME, Giannobile WV, Payne J, Sorsa T (1998). Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv Dent Res12: 12-26.
18. Golub LM, McNamara TF, Ryan ME et al (2001). Adjunctive treatment with subantimicrobial doses of doxycycline: effects on gingival fluid collagenase activity and attachment loss in adult periodontitis. J Clin Periodontol28: 146-156.
19. Golub LM, Lee HM, Stoner JA et al (2008). Subantimicrobial-dose doxycycline modulates gingival crevicular fluid biomarkers of periodontitis in postmenopausal osteopenic women. J Periodontol79: 1409-1418.
20. Grossi SG, Skrepcinski FB, DeCaro T et al (1997). Treatment of periodontal disease in diabetics reduces glycated hemoglobin. J Periodontol68: 713-719.
21. Hernandez M, Gamonal J, Tervahartiala T et al (2010). Associations between matrix metalloproteinase-8 and -14 and myeloperoxidase in gingival crevicular fluid from subjects with progressive chronic periodontitis: a longitudinal study. J Periodontol81: 1644-1652.
22. Kardeşler L, Biyikoǧlu B, Çetinkalp Ş, Pitkala M, Sorsa T, Buduneli N (2010a). Crevicular fluid matrix metalloproteinase-8, -13, and TIMP-1 levels in type 2 diabetics. Oral Dis16: 476-481.
23. Kardeşler L, Buduneli N, Çetinkalp Ş, Kinane DF (2010b). Adipokines and inflammatory mediators after initial periodontal treatment in patients with type 2 diabetes and chronic periodontitis. J Periodontol81: 24-33.
24. Khader YS, Al Habashneh R, Al Malalheh M, Bataineh A (2010). The effect of full-mouth tooth extraction on glycemic control among patients with type 2 diabetes requiring extraction of all remaining teeth: a randomized clinical trial. J Periodontal Res45: 741-747.
25. Killoy WJ (1998). The use of locally-delivered chlorhexidine in the treatment of periodontitis. Clinical results. J Clin Periodontol25: 953-958.
26. Kinane DF, Darby IB, Said S et al (2003). Changes in gingival crevicular fluid matrix metalloproteinase-8 levels during periodontal treatment and maintenance. J Periodontal Res38: 400-404.
27. Kiran M, Arpak N, Unsal E, Erdogan MF (2005). The effect of improved periodontal health on metabolic control in type diabetes mellitus. J Clin Periodontol32: 266-272.
28. Kumar MS, Vamsi G, Sripriya R, Sehgal PK (2006). Expression of matrix metalloproteinases (MMP-8 and -9) in chronic periodontitis patients with and without diabetes mellitus. J Periodontol77: 1803-1808.
29. Lange DE, Plagmann HC, Eenboom A, Promesberger A (1977). Clinical methods for the objective evaluation of oral hygiene. Dtsch Zahnarztl Z32: 44-47.
30. Lee JY, Lee YM, Shin SY et al (2004). Effect of subantimicrobial dose doxycycline as an effective adjunct to scaling and root planing. J Periodontol75: 1500-1508.
31. Leppilahti J, Ahonen MM, Hernández M et al (2011). Oral rinse MMP-8 point-of-care immuno test identifies patients with strong periodontal inflammatory burden. Oral Dis17: 115-122.
32. Marcaccini AM, Meschiari CA, Zuardi LR et al (2010). Gingival crevicular fluid levels of MMP-8, MMP-9, TIMP-2, and MPO decrease after periodontal therapy. J Clin Periodontol37: 180-190.
33. Miller LS, Manwell MA, Newbold D et al (1992). The relationship between reduction in periodontal inflammation and diabetes control: a report of 9 cases. J Periodontol63: 843-848.
34. Navarro-Sanchez AB, Faria-Almeida R, Bascones-Martinez A (2007). Effect of non-surgical periodontal therapy on clinical and immunological response and glycaemic control in type 2 diabetic patients with moderate periodontitis. J Clin Periodontol34: 835-843.
35. Nesse W, Linde A, Abbas F et al (2009). Dose-response relationship between periodontal inflamed surface area and HbA1c in type 2 diabetics. J Clin Periodontol36: 295-300.
36. Nishimura F, Takahashi K, Kurihara M, Takashiba S, Murayama Y (1998). Periodontal disease as a complication of diabetes mellitus. Ann Periodontol3: 20-29.
37. Özçaka Ö, Biçakci N, Pussinen P, Sorsa T, Köse T, Buduneli N (2011). Smoking and matrix metalloproteinases, neutrophil elastase and myeloperoxidase in chronic periodontitis. Oral Dis17: 68-76.
38. Preshaw PM, Hefti AF, Novak MJ et al (2004). Subantimicrobial dose doxycycline enhances the efficacy of scaling and root planing in chronic periodontitis: a multicenter trial. J Periodontol75: 1068-1076.
39. Promsudthi A, Pimapansri S, Deerochanawong C, Kanchanavasita W (2005). The effect of periodontal therapy on uncontrolled type 2 diabetes mellitus in older subjects. Oral Dis11: 293-298.
40. Quirynen M, Bollen CM, Vandekerckhove BN, Dekeyser C, Papaioannou W, Eyssen H (1995). Full- vs. partial-mouth disinfection in the treatment of periodontal infections: short-term clinical and microbiological observations. J Dent Res74: 1459-1467.
41. Rodrigues DC, Tabe MJ, Novaes AB, Souza SL, Grisi MF (2003). Effect of non-surgical periodontal therapy on glycemic control in patients with type 2 diabetes mellitus. J Periodontol74: 1361-1367.
42. Rohlfing CL, Wiedemeyer HM, Little RR, England JD, Tennill A, Goldstein DE (2002). Defining the relationship between plasma glucose and HbA1c: analysis of glucose profile and HbA1c in the diabetes control and complications trial. Diabetes Care25: 275-278.
43. Ross JH, Hardy DC, Schuyler CA, Slate EH, Mize TW, Huang Y (2010). Expression of periodontal interleukin-6 protein is increased across patients with neither periodontal disease nor diabetes, patients with periodontal disease alone and patients with both diseases. J Periodontal Res45: 688-694.
44. Sgolastra F, Petrucci A, Gatto R, Giannoni M, Monaco A (2011). Long-term efficacy of subantimicrobial-dose doxycycline as an adjunctive treatment to scaling and root planing: a systematic review and meta-analysis. J Periodontol82: 1570-1581.
45. Sima C, Rhourida K, Van Dyke TE, Gyurko R (2010). Type 1 diabetes predisposes to enhanced gingival leukocyte margination and macromolecule extravasation in vivo. J Periodontal Res45: 748-756.
46. Sorsa T, Uitto VJ, Suomalainen K, Vauhkinen M, Lindy S (1988). Comparison of interstitial collagenases from human gingival, sulcular fluid and polymorphonuclear leukocytes. J Periodontal Res23: 386-393.
47. Sorsa T, Hernández M, Leppilahti J, Munjal S, Netuschil L, Mäntylä P (2010). Detection of gingival crevicular fluid MMP-8 levels with different laboratory and chair-side methods. Oral Dis16: 39-45.
48. Stewart JE, Pager KA, Friedlander AH, Zadeh HH (2001). The effect of periodontal treatment on glycemic control in patients with type 2 diabetes mellitus. J Clin Periodontol28: 306-310.
49. Tervonen T, Lamminsalo S, Hiltunen L, Raunio T, Knuuttila M (2009). Resolution of periodontal inflammation does not guarantee improved glycemic control in type 1 diabetic subjects. J Clin Periodontol36: 51-57.
50. Tüter G, Serdar M, Kurtis B et al (2010). Effects of scaling and root planing and subantimicrobial dose doxycycline on gingival crevicular fluid levels of matrix metalloproteinase-8, -13 and serum levels of HsCRP in patients with chronic periodontitis. J Periodontol81: 1132-1139.
51. Yalda B, Offenbacher S, Collins G (1994). Diabetes as a modifier of periodontal disease expression. Periodontol 20006: 37-49.